Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.380
-0.120 (-8.00%)
Oct 13, 2026, 1:22 PM EDT - Market open
Equillium Market Cap
Equillium has a market cap or net worth of $87.5 million as of October 13, 2026. It is the 25,727th most valuable company in the world and the 4,155th biggest in the United States. Its market cap has increased by 9.79% in one year.
Market Cap
87.50M
Enterprise Value
30.92M
1-Year Change
9.79%
Global Rank
Country Rank
#4,155 United States
Category
ChartMarket Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $233.80M to $87.50M, a decrease of -62.57%. That is a compound annual growth rate of -11.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 87.50M | -7.31% |
| Dec 31, 2025 | 94.40M | 256.23% |
| Dec 31, 2024 | 26.50M | 4.33% |
| Dec 29, 2023 | 25.40M | -30.22% |
| Dec 30, 2022 | 36.40M | -67.15% |
| Dec 31, 2021 | 110.80M | -16.25% |
| Dec 31, 2020 | 132.30M | 125.38% |
| Dec 31, 2019 | 58.70M | -58.60% |
| Dec 31, 2018 | 141.80M | -39.35% |
| Oct 12, 2018 | 233.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 95.16M |
| Cellectis | 91.82M |
| Rallybio | 90.38M |
| Neumora Therapeutics | 89.38M |
| ImmuCell | 89.01M |
| NeurAxis | 87.03M |
| ProMIS Neurosciences | 86.18M |
| Cardiff Oncology | 84.02M |